CRPO.F Stock Overview
Ceapro Inc., a biotechnology company, engages in the development and marketing of health and wellness products and technology relating to plant extracts in the United States, Germany, China, Canada, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Ceapro Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.18 |
| 52 Week High | CA$0.44 |
| 52 Week Low | CA$0.11 |
| Beta | 1.39 |
| 1 Month Change | 7.93% |
| 3 Month Change | 57.56% |
| 1 Year Change | -56.07% |
| 3 Year Change | -68.19% |
| 5 Year Change | -35.04% |
| Change since IPO | 108.95% |
Recent News & Updates
Recent updates
Shareholder Returns
| CRPO.F | US Chemicals | US Market | |
|---|---|---|---|
| 7D | 4.2% | 0.3% | 1.2% |
| 1Y | -56.1% | 8.9% | 24.9% |
Return vs Industry: CRPO.F underperformed the US Chemicals industry which returned 8.9% over the past year.
Return vs Market: CRPO.F underperformed the US Market which returned 24.7% over the past year.
Price Volatility
| CRPO.F volatility | |
|---|---|
| CRPO.F Average Weekly Movement | n/a |
| Chemicals Industry Average Movement | 5.5% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: CRPO.F's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine CRPO.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1997 | n/a | Gilles Gagnon | www.ceapro.com |
Ceapro Inc., a biotechnology company, engages in the development and marketing of health and wellness products and technology relating to plant extracts in the United States, Germany, China, Canada, and internationally. The company is involved in the development of proprietary extraction technologies and the application of these technologies to the production, development, and commercialization of active ingredients, such as oat beta glucan and avenanthramides, which are derived from oats and other renewable plant resources for healthcare and cosmetic industries. It also offers natural active ingredients, including oat powder, oat oil, oat peptides, and lupin peptides to the personal care, cosmetic, medical, and animal health industries; anti-aging skincare products to the cosmeceutical industries; and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.
Ceapro Inc. Fundamentals Summary
| CRPO.F fundamental statistics | |
|---|---|
| Market cap | US$13.69m |
| Earnings (TTM) | -US$2.05m |
| Revenue (TTM) | US$8.24m |
1.7x
P/S Ratio-6.7x
P/E RatioIs CRPO.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CRPO.F income statement (TTM) | |
|---|---|
| Revenue | CA$11.30m |
| Cost of Revenue | CA$6.34m |
| Gross Profit | CA$4.96m |
| Other Expenses | CA$7.77m |
| Earnings | -CA$2.81m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.036 |
| Gross Margin | 43.88% |
| Net Profit Margin | -24.86% |
| Debt/Equity Ratio | 0% |
How did CRPO.F perform over the long term?
See historical performance and comparison